Cholesterol Testing Market to Witness Rapid Growth until 2025
Increasing incidences of
cardiovascular diseases and supportive government initiatives to improve
quality of testing to drive global cholesterol testing market
According
to TechSci Research report, “Global Cholesterol
Testing Market By Indication (Atherosclerosis, Diabetes, Obesity, Others), By
Product (Test Strips, Test Kits), By End-Product (Total cholesterol, High-density
lipoprotein cholesterol, Low-density lipoprotein cholesterol, Triglycerides),
By Test (Lipid Panel Test, Apolipoprotein B Test, Others), By Age (Before Puberty,
Puberty, Adulthood), By End-User (Hospitals & Clinics, Homecare,
Others), By Region, Forecast &
Opportunities, 2025”, the global cholesterol
testing market is expected to witness rapid growth during the forecast period.
This can be attributed to increasing incidence of cardiovascular diseases,
obesity, technological advancements in cholesterol testing, rise in geriatric
population and growing awareness towards healthcare. Furthermore, increase in
healthcare expenditure and rise in public awareness about various
cardiovascular diseases is anticipated to drive the market in the coming years.
Moreover, high cholesterol has no symptoms; hence it requires a complete
cholesterol testing. Consumers are now aware of the risks associated with
elevated levels of cholesterol and the increasing chances of heart diseases due
to it. Therefore, they prefer keeping a check on their cholesterol level. Also,
physicians now a days are preferring for lab testing over self-testing, besides
growing awareness and adoption of preventive healthcare. Additionally, rise in public awareness about cardiovascular disease,
health risks associated with it, causes, treatment, and prevention is further
anticipated to fuel the growth of cholesterol testing market. Moreover, ever
evolving home/self-testing market and emergence of noninvasive cholesterol
testing methods are also expected to boost the global cholesterol testing
market across the globe. Furthermore, growing cases of thyroid disorders, especially among
women and adults is also fueling the cholesterol testing market as hypothyroidism
causes disruption of lipid metabolism and requires cholesterol check. However,
the global cholesterol testing market might also face some hindrance in its
growth. Swift growth in self-testing devices and emergence of noninvasive
cholesterol testing approaches might prove as a threat to the overall growth of
cholesterol testing market.
Browse
XX market data Tables and XX Figures spread through XXX
Pages and an in-depth TOC on"Global Cholesterol Testing Market"
https://www.techsciresearch.com/report/cholesterol-testing-market/4663.html
The global
cholesterol testing market is segmented based on indication, product, end
product, test, age, end-user, and region. Based on product, the market is
segmented into test strips, and test kits. The test kits segment is further
divided into without meter, with meter and mail-in. Among these, test kits
segment is anticipated to hold largest market share in terms of revenue during
the forecast years as they are the most convenient and effective way to test
cholesterol levels and allow the monitoring of cholesterol without visiting the
doctor and give test results in minutes. Based on test, the global cholesterol
testing market is segmented into Lipid Panel Test/Complete Lipid Profile,
Apolipoprotein B Test, Apolipoprotein A-1 Test, Apoe Genotyping Test,
Apolipoprotein CII and others. Lipid panel test or complete lipid profile is expected
to dominate the market until 2025 owing to the fact that the results of this
test can identify certain genetic diseases and can determine approximate risks
for cardiovascular disease, certain forms of pancreatitis, and other diseases.
Major players operating in the global cholesterol
testing market include Abaxis, Inc., Abbott
Laboratories, Akers Biosciences, Inc., Beckman Coulter, Inc., Bio-Reference
Laboratories, Boston Heart Diagnostics Corporation, Cell Biolabs, Inc, Clinical
Reference Laboratory, Inc., F. Hoffmann-La Roche Ltd, Prima Lab SA, PTS Diagnostics,
Quest Diagnostics, Randox Laboratories, Sekisui Diagnostics, LLC, Siemens
Healthineers, Sigma-Aldrich Corporation, Spectra Laboratories, SpectraCell
Laboratories, Inc, Thermo Fisher Scientific, Unilabs and others. The companies
are focusing on development of new and advanced monitoring devices to overcome
the challenges in existing testing devices and hence the global market for
cholesterol testing is highly competitive.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4663
Customers can also request for 10% free customization on
this report.
“Emerging economies like China and India are serving
as evolving markets for cholesterol testing companies due to the prevalence of
poor dietary habits and lifestyle patterns in these two nations. Additionally,
the key market players are gaining cooperation from international bodies and
local government agencies with an aim to provide quality diagnostic testing
services across the world. This is anticipated to further boost the cholesterol
testing market in the coming years. Also, medicare and medical benefits
provided by organisations to their employees would also help fuel the overall
growth of the market.,” said
Mr. Karan Chechi, Research Director with TechSci Research, a research based
global management consulting firm.
“Global Cholesterol Testing Market By Indication (Atherosclerosis,
Diabetes, Obesity, Others), By Product (Test Strips, Test Kits), By End-Product
(Total cholesterol, High-density lipoprotein cholesterol, Low-density
lipoprotein cholesterol, Triglycerides), By Test (Lipid Panel Test,
Apolipoprotein B Test, Others), By Age
(Before Puberty, Puberty, Adulthood), By End-User
(Hospitals & Clinics, Homecare, Others),
By Region, Forecast & Opportunities, 2025”, has evaluated the future growth potential of global cholesterol
testing market and provides statistics & information on market size,
structure and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges and opportunities in global cholesterol testing market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]